Cnf1 Variants Endowed with the Ability to Cross the Blood–Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma

Glioblastoma: Targeting the autophagy in tumorigenesis

(2019) Kang Yang et al.   BRAIN RESEARCH BULLETIN

The Escherichia coli protein toxin cytotoxic necrotizing factor 1 induces epithelial mesenchymal transition

(2019) Alessia Fabbri et al.   CELLULAR MICROBIOLOGY

The Bacterial Protein CNF1 as a Potential Therapeutic Strategy against Mitochondrial Diseases: A Pilot Study

(2018) Alessia Fabbri et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Host with the most: Targeting host cells instead of pathogens to fight infectious disease

(2017) Amanda B. Keener   NATURE MEDICINE

Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stages

(2017) Eleonora Vannini et al.   Oncotarget

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Rational engineering of single-chain polypeptides into protein-only, BBB-targeted nanoparticles

(2016) Naroa Serna et al.   Nanomedicine-Nanotechnology Biology and Medicine

Electrophysiology of glioma: a Rho GTPase-activating protein reduces tumor growth and spares neuron structure and function

(2016) Eleonora Vannini et al.   NEURO-ONCOLOGY

Modulation of Rho GTPases rescues brain mitochondrial dysfunction, cognitive deficits and aberrant synaptic plasticity in female mice modeling Rett syndrome

(2015) Bianca De Filippis et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Mitochondrial free radical overproduction due to respiratory chain impairment in the brain of a mouse model of Rett syndrome: protective effect of CNF1

(2015) Bianca De Filippis et al.   FREE RADICAL BIOLOGY AND MEDICINE

CNF1 Enhances Brain Energy Content and Counteracts Spontaneous Epileptiform Phenomena in Aged DBA/2J Mice

(2015) Sara Travaglione et al.   PLoS One

The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model

(2014) Eleonora Vannini et al.   BMC CANCER

Enhancement of mitochondrial ATP production by theEscherichia colicytotoxic necrotizing factor 1

(2014) Sara Travaglione et al.   FEBS Journal

High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer

(2013) Emmanuel Buc et al.   PLoS One

Correction: CNF1 Increases Brain Energy Level, Counteracts Neuroinflammatory Markers and Rescues Cognitive Deficits in a Murine Model of Alzheimer's Disease

(2013) Stefano Loizzo et al.   PLoS One

Modulation of RhoGTPases Improves the Behavioral Phenotype and Reverses Astrocytic Deficits in a Mouse Model of Rett Syndrome

(2011) Bianca De Filippis et al.   NEUROPSYCHOPHARMACOLOGY

Mitochondrial fusion and fission in cell life and death

(2010) Benedikt Westermann   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Escherichia coli Cytotoxic Necrotizing Factor 1 (CNF1): Toxin Biology, in Vivo Applications and Therapeutic Potential

(2010) Alessia Fabbri et al.   Toxins

Cleavage of Escherichia coli Cytotoxic Necrotizing Factor 1 Is Required for Full Biologic Activity

(2009) Z. Knust et al.   INFECTION AND IMMUNITY

Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2

(2008) Michel Demeule et al.   JOURNAL OF NEUROCHEMISTRY